are combination approaches the way forward for treating patients with triple-negative breast cancer?
Published 2 years ago • 64 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:58
promising novel approaches to the treatment of tnbc
-
1:07
precision medicine for metastatic triple-negative breast cancer
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
1:04
future directions in triple-negative breast cancer research
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
0:53
enhancing triple negative breast cancer treatment with immunotherapy across all settings
-
2:30
highlighting a subset of tnbc for targeted therapy
-
0:41
recent advances in targeted therapies for tnbc
-
2:05
treatment advances in tnbc
-
1:24
combining chemotherapy, cd40 agonist, and flt3 ligand in triple-negative breast cancer
-
2:42
biomarker-driven therapies for triple-negative breast cancer
-
23:52
breast cancer and the immune system at mbc patient forum 2019
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
1:15
clinical implications of progress in tnbc therapies
-
3:50
clinical approach to triple-negative breast cancer
-
28:25
metastatic triple-negative breast cancer ongoing trials